Lipid-lowering medication reduces more target lesion than non-target lesion revascularizations: a cohort study

Authors

Institutions

Publication Details

Journal
Annals of Medicine
Published
2026-02-12
DOI
https://doi.org/10.1080/07853890.2026.2625586
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lipid-lowering medication reduces more target lesion than non-target lesion revascularizations: a cohort study

Mitja Lääperi, Elina Mantyniemi, Juha Sinisalo
Annals of Medicine
Cancer, Lipids, and Metabolism
article

Lipid-lowering medication reduces more target lesion than non-target lesion revascularizations: a cohort study

Mitja Lääperi, Elina Mantyniemi, Juha Sinisalo
article en

Abstract

No abstract available for this paper.
Annals of MedicineVol. 58(1)
University of Helsinki (FI), Helsinki University Hospital (FI), Statistical Service (CY), Statistical Research (United States) (US)
Openalex Percentile: Top 59%
Cancer, Lipids, and Metabolism
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lipid-lowering medication reduces more target lesion than non-target lesion revascularizations: a cohort study — Mitja Lääperi, Elina Mantyniemi, et al. · Annals of Medicine (2026) | TGRS Research Map | TGRS